Status:
COMPLETED
Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19
Lead Sponsor:
Ankara Education and Research Hospital
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
In patients with coronavirus disease (COVID-19), severe dyspnea is the most dramatic complication.Severe respiratory difficulties may include electrocardiographic frontal QRS axis rightward shift (Rws...
Detailed Description
The lung is the most seriously damaged organ in patients with coronavirus disease (COVID-19). In patients with advanced lung involvement, the alveoli are filled with fluid, white blood cells, mucus, a...
Eligibility Criteria
Inclusion
- Hospitalized patients with dyspnea and COVID-19
Exclusion
- Patients who received positive pressurized oxygen therapy Patients who underwent mechanical ventilation, Atrial fibrillation Complete bundle branch block Significant arrhythmias(complete atrioventricular block, polymorphic ventricular tachycardia, and ventricular fibrillation), Wolff-Parkinson-White syndrome, supraventricular tachycardia Unclear QRS axis orientation.
- \-
Key Trial Info
Start Date :
July 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04698083
Start Date
July 22 2020
End Date
November 5 2020
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Şahbender Koç
Ankara, Turkey (Türkiye), 06530